BERLIN, June 1, 2007 - The Berlin-based biotech company MOLOGEN AG has sold its Spanish subsidiary Vivotecnia Research S. L. The purchase was financed by Spanish investors who are to drive forward the further expansion of Vivotecnia. MOLOGEN received sales proceeds of around EUR 1.1 million for its interest of approximately 90%. The transfer of shares was effective force on 30 May 2007.
